2004
DOI: 10.1016/j.expneurol.2003.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
48
2

Year Published

2007
2007
2016
2016

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(54 citation statements)
references
References 64 publications
4
48
2
Order By: Relevance
“…In addition, overexpression generates vast amounts of protein that could enable an unrepresentative large detectable reduction in protein levels in intervention studies. Furthermore, the Tg NSE/APPsw mouse model used by Um et al [12] does not develop plaques, as seen in human patients with AD [36]. The abovementioned concern suggests that the different pathology of Aβ in the mouse makes direct comparison of the effect of an exercise intervention between humans and animal models less valid and could account for the disagreement between our findings and previous animal findings.…”
Section: Discussioncontrasting
confidence: 57%
“…In addition, overexpression generates vast amounts of protein that could enable an unrepresentative large detectable reduction in protein levels in intervention studies. Furthermore, the Tg NSE/APPsw mouse model used by Um et al [12] does not develop plaques, as seen in human patients with AD [36]. The abovementioned concern suggests that the different pathology of Aβ in the mouse makes direct comparison of the effect of an exercise intervention between humans and animal models less valid and could account for the disagreement between our findings and previous animal findings.…”
Section: Discussioncontrasting
confidence: 57%
“…There is considerable evidence that one mechanism by which neurons die in AD is apoptosis (for review, see LeBlanc, 2005). Indeed, several groups have reported the presence of activated caspases in the postmortem brains of individuals with AD (Selznick et al, 1999;Stadelmann et al, 1999;Raina et al, 2001) and have described apoptotic neurons in the brains of transgenic mouse models for AD (LaFerla et al, 1995;Chui et al, 1999;Xie et al, 2001;Hwang et al, 2004). We showed previously that exogenous expression of FAD APP mutations or of APP-BP1 in primary neurons causes cell cycle entry followed by apoptosis (McPhie et al, 1997(McPhie et al, , 2001).…”
Section: Discussionmentioning
confidence: 99%
“…NSE/APPsw Tg mice expressing the human APPsw gene under the control of the neuron-specific enolase (NSE) promoter were used for this study. These mice present AD phenotypes, including behavioral dysfunction, Aß-42 deposition and apoptosis activation at 12-13 months of age (23). The Non-Tg and Tg mice were obtained from the Department of Laboratory Animal Resources at the National Institute of Toxicological Research, Korea FDA.…”
Section: Methodsmentioning
confidence: 99%
“…Western blot analyses were conducted as previously described (23). Briefly, proteins (40 μg) were separated by electrophoresis on a 10% polyacrylamide gel for 3 h, after which they were transferred to a nitrocellulose membrane (Immuno-Blot, PVDF membrane, Bio-Rad, CA, USA) for 2 h at a constant voltage of 40 volts.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation